Head to Head Review: BELLUS Health (OTCMKTS:BLUSF) & Flora Growth (NASDAQ:FLGC)

BELLUS Health (OTCMKTS:BLUSFGet Rating) and Flora Growth (NASDAQ:FLGCGet Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership.

Insider & Institutional Ownership

8.1% of Flora Growth shares are held by institutional investors. 24.2% of BELLUS Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares BELLUS Health and Flora Growth’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BELLUS Health -49,910.34% -48.37% -45.25%
Flora Growth N/A N/A N/A

Earnings and Valuation

This table compares BELLUS Health and Flora Growth’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BELLUS Health $30,000.00 43,863.25 -$7.01 million N/A N/A
Flora Growth $8.98 million 7.65 -$14.17 million N/A N/A

BELLUS Health has higher earnings, but lower revenue than Flora Growth.

Analyst Recommendations

This is a summary of recent recommendations for BELLUS Health and Flora Growth, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BELLUS Health 0 0 0 0 N/A
Flora Growth 0 0 2 0 3.00

Flora Growth has a consensus price target of $10.75, suggesting a potential upside of 726.92%. Given Flora Growth’s higher probable upside, analysts plainly believe Flora Growth is more favorable than BELLUS Health.

Summary

Flora Growth beats BELLUS Health on 7 of the 10 factors compared between the two stocks.

About BELLUS Health (Get Rating)

BELLUS Health, Inc. is a biopharmaceutical development company, which engages in the research and development of products that provide health solutions and address critical unmet medical needs. Its products include BLU-5937, KIACTA, AMO-01, and ALZ-801. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

About Flora Growth (Get Rating)

Flora Growth Corp., a cannabis company, cultivates, processes, and supplies cannabis products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis oil extracts and related products; manufactures and sells skincare and beauty products, such as gel cleanser, eye cream, moisturizer, and hydrating mask; manufactures dermo cosmetic products; and develops and sells pharmaceutical and over-the-counter products, including dietary supplements, phytotherapeutic and nutraceutical products, supplements, and related products. It also manufactures and sells hemp textiles products focuses on servicing the hospitality, medical, and clothing industries on a B2B basis; designs, produces, and supplies juices, chocolate, and chocolate related products to wholesale distributors, pharmacies, supermarkets, and online distributors; and offers and wellness products. The company's brand includes Mambe, Mind Naturals, Almost Virgin, Flora Lab, and Stardog Loungewear. The company was incorporated in 2019 and is headquartered in Toronto, Canada.

Receive News & Ratings for BELLUS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BELLUS Health and related companies with MarketBeat.com's FREE daily email newsletter.